ÖZ
Amaç
Bu çalışmanın amacı, inme hastalarında botulinum toksin enjeksiyonunun üst ekstremite kas kalınlığı ve motor iyileşme üzerine etkilerini araştırmaktır.
Gereç ve Yöntem
Çalışma retrospektif olarak yürütülmüştür. Üst ekstremite ön kol kaslarına botulinum toksin enjeksiyonu uygulanan yirmi inme hastası (11 erkek, 9 kadın) çalışmaya dahil edilmiştir. Kas kalınlığı ölçümleri, brunnstrom motor iyileşme evreleri ve modifiye Ashworth Skalası skorları, botulinum toksin enjeksiyonundan önce ve bir ay sonra değerlendirilmiştir.
Bulgular
Botulinum toksin uygulamasından önce ve sonra brunnstrom üst ekstremite ve el evrelerinde anlamlı bir değişiklik görülmemiştir (p>0,05). Enjeksiyonlardan önce veya sonra ön kolun volar yüzeyinin proksimal üçte birinden alınan ölçümlerde ön kol kas kalınlığında anlamlı bir değişiklik gözlenmedi (p>0,05). Botulinum toksin uygulamasından sonra el bilek fleksör grubu ve el parmak fleksör grubu kaslarının spastisite düzeylerinde anlamlı bir azalma gözlendi (p=0,001).
Sonuç
Çalışma, botulinum toksinin spastisiteyi azalttığını ancak brunnstrom motor iyileşmesi ve kas kalınlığı üzerinde bir etkisi olmadığını göstermektedir.
Anahtar Kelimeler:
İnme, botulinum toksin enjeksiyonu, spastisite, kas kalınlığı, brunnstrom motor iyileşme evresi
Kaynaklar
1
Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020;21:7609.
2
Francisco GE, Wissel J, Platz T, Li S. Post-Stroke Spasticity. Clinical pathways in stroke rehabilitation: evidence-based clinical practice recommendations [Internet]. Cham (CH): Springer; 2021.
3
Khan F, Amatya B, Bensmail D, Yelnik A. Non-pharmacological interventions for spasticity in adults: an overview of systematic reviews. Ann Phys Rehabil Med. 2019;62:265-73.
4
Li S, Francisco GE. The use of botulinum toxin for treatment of spasticity. Handb Exp Pharmacol. 2021;263:127-46.
5
Hara T, Momosaki R, Niimi M, Yamada N, Hara H, Abo M. Botulinum toxin therapy combined with rehabilitation for stroke: a systematic review of the effect on motor function. Toxins (Basel). 2019;11:707.
6
Francis HP, Wade DT, Turner-Stokes L, Kingswell RS, Dott CS, Coxon EA. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol Neurosurg Psychiatry. 2004;75:1547-51.
7
Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, et al. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Health Technol Assess. 2010;14:1-113.
8
Devis M, Lecouvet F, Lejeune T, Stoquart G. Noninvasive analysis of overactive muscle structure and elasticity after botulinum toxin type a injection: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2024;60:567-80.
9
Picelli A, Filippetti M, Melotti C, Guerrazzi F, Modenese A, Smania N. Does botulinum toxin treatment affect the ultrasonographic characteristics of post-stroke spastic equinus? A retrospective pilot study. Toxins (Basel). 2020;12:797.
10
Ma J, Elsaidi GA, Smith TL, Walker FO, Tan KH, Martin E, et al. Time course of recovery of juvenile skeletal muscle after botulinum toxin a injection: an animal model study. Am J Phys Med Rehabil. 2004;83:774-83.
11
Alexander C, Elliott C, Valentine J, Stannage K, Bear N, Donnelly C, et al. Muscle volume alterations after first botulinum neurotoxin a treatment in children with cerebral palsy: a 6-month prospective cohort study. Dev Med Child Neurol. 2018;60:1165-71.
12
Tok F, Ozçakar L, Safaz I, Alaca R. Effects of botulinum toxin-a on the muscle architecture of stroke patients: the first ultrasonographic study. J Rehabil Med. 2011;43:1016-9.
13
Yi YG, Jang DH, Lee D, Oh JY, Han MH. Botulinum toxin injection in children with hemiplegic cerebral palsy: correction of growth through comparison of treated and unaffected limbs. Toxins (Basel). 2019;11:688.
14
Sun LC, Chen R, Fu C, Chen Y, Wu Q, Chen R, et al. Efficacy and safety of botulinum toxin type a for limb spasticity after stroke: a meta-analysis of randomized controlled trials. Biomed Res Int. 2019;2019:8329306.
15
Baker JA, Pereira G. The efficacy of botulinum toxin a for spasticity and pain in adults: a systematic review and meta-analysis using the grades of recommendation, assessment, development and evaluation approach. Clin Rehabil. 2013;27:1084-96.
16
Guyot P, Kalyvas C, Mamane C, Danchenko N. Botulinum toxins type A (BoNT-A) in the management of lower limb spasticity in children: a systematic literature review and Bayesian network meta-analysis. J Child Neurol. 2019;34:371-81.
17
Sawner KA, LaVigne JM, Brunnstrom S: Brunnstrom’s movement therapy in hemiplegia : a neurophysiological approach. Philadelphia: Lippincott. 1992.
18
Li F, Wu Y, Li X. Test-retest reliability and inter-rater reliability of the Modified Tardieu scale and the modified Ashworth scale in hemiplegic patients with stroke. Eur J Phys Rehabil Med. 2014;50:9-15.
19
Varvarousis DN, Martzivanou C, Dimopoulos D, Dimakopoulos G, Vasileiadis GI, Ploumis A. The effectiveness of botulinum toxin on spasticity and gait of hemiplegic patients after stroke: a systematic review and meta-analysis. Toxicon. 2021;203:74-84.
20
Picelli A, Santamato A, Cosma M, Baricich A, Chisari C, Millevolte M, et al. Early botulinum toxin type a injection for post-stroke spasticity: a longitudinal cohort study. Toxins (Basel). 2021;13:374.
21
Uchiyama Y, Koyama T, Wada Y, Katsutani M, Kodama N, Domen K. Botulinum toxin type a treatment combined with intensive rehabilitation for gait poststroke: a preliminary study. J Stroke Cerebrovasc Dis. 2018;27:1975-86.
22
Prazeres A, Lira M, Aguiar P, Monteiro L, Vilasbôas Í, Melo A. Efficacy of physical therapy associated with botulinum toxin type a on functional performance in post-stroke spasticity: a randomized, double-blinded, placebo-controlled trial. Neurol Int. 2018;10:7385.
23
Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke. J Rehabil Med. 2014;46:730-7.
24
Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair. 2012;26:812-21.
25
Lim YH, Choi EH, Lim JY. Comparison of effects of botulinum toxin injection between subacute and chronic stroke patients: a pilot study. Medicine (Baltimore). 2016;95:e2851.
26
Devier D, Harnar J, Lopez L, Brashear A, Graham G. Rehabilitation plus onabotulinumtoxinA improves motor function over onabotulinumtoxinA alone in post-stroke upper limb spasticity: a single-blind, randomized trial. Toxins (Basel). 2017;9:216.
27
Çelebi G, Ayyildiz A, Çiftci Inceoğlu S, Kuran B. The effect of ultrasound-guided botulinum toxin injections on pain, functionality, spasticity, and range of motion in patients with post-stroke upper extremity spasticity. Rehabilitacion (Madr). 2025;59:100876.
28
Hesse S, Mach H, Fröhlich S, Behrend S, Werner C, Melzer I. An early botulinum toxin a treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial. Clin Rehabil. 2012;26:237-45.
29
Lieber RL, Fridén J. Functional and clinical significance of skeletal muscle architecture. Muscle Nerve. 2000;23:1647-66.
30
Ruggiero M, Cless D, Infantolino B. Upper and Lower limb muscle architecture of a 104 year-old cadaver. PLoS One. 2016;11:e0162963.
31
Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol. 2000;89:81-8.
32
Koo HJ, Hu H, Kim W, Kim JS, Kim HJ, Yi KH. Do repetitive botulinum neurotoxin injections induce muscle fibrosis? Sonographic observation of the masseter muscle. J Cosmet Dermatol. 2024;23:434-40.
33
Fortuna R, Vaz MA, Youssef AR, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox). J Biomech. 2011;44:39-44.
34
González-Buonomo J, Pham AH, Ghuman J, Malik A, Yozbatiran N, Francisco GE, et al. Ultrasound assessment of spastic muscles in ambulatory chronic stroke survivors reveals function-dependent changes. J Rehabil Med. 2023;55:jrm00342.
35
Agat EM, Horstmann K, Francisco GE, Li S. Ultrasound assessment of muscle and fascia properties and the effects of spasticity and botulinum toxin injections on spastic muscles in chronic stroke survivors. Am J Phys Med Rehabil. 2025;104:527-33.
36
Mathevon L, Michel F, Decavel P, Fernandez B, Parratte B, Calmels P. Muscle structure and stiffness assessment after botulinum toxin type A injection: a systematic review. Ann Phys Rehabil Med. 2015;58:343-50.
